Augmentation of Therapeutic Angiogenesis Using Genetically Modified Human Endothelial Progenitor Cells with Altered Glycogen Synthase Kinase-3β Activity
Jin‐Ho Choi(Samsung Medical Center), Hyo-Soo Kim(Seoul National University)
Cited by 96
Related Papers
KAI1(CD82) is a key molecule to control angiogenesis and switch angiogenic milieu to quiescent state
|Journal of Hematology & Oncology|2021|49